146 related articles for article (PubMed ID: 4155008)
1. Influence of the beta-adrenergic blocking drug Kö 1366 on haemodynamics in healthy volunteers and patients with ischaemic heart disease.
Miyahara M; Fujise Y; Osanai S; Takada T
Jpn Heart J; 1974 Sep; 15(5):455-68. PubMed ID: 4155008
[No Abstract] [Full Text] [Related]
2. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
[No Abstract] [Full Text] [Related]
3. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
Coleman AJ; Leary WP; Asmal AC
Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
[No Abstract] [Full Text] [Related]
4. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
Franciosa JA; Freis ED; Conway J
Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
[No Abstract] [Full Text] [Related]
5. [Simultaneous application of a beta-adrenergic sympathicomimetic and beta-adrenergic antagonist during inhibition of labor (author's transl)].
Müller-Tyl E; Reinold E; Hernuss P
Z Geburtshilfe Perinatol; 1974 Apr; 178(2):128-34. PubMed ID: 4154069
[No Abstract] [Full Text] [Related]
6. Preliminary report on the haemodynamic response of hypertensive patients treated with a beta blocker (ICI 66082).
Amery A; Billiet L; Joossens JV; Meekers J; Reybrouck T; Van Mieghem W
Acta Clin Belg; 1973; 28(5):358-63. PubMed ID: 4149691
[No Abstract] [Full Text] [Related]
7. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
Gilfrich HJ; Rahn KH; Nicolescu RF
Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
[No Abstract] [Full Text] [Related]
8. Double blind cross-over study of the inotropic influence of Tiprenolol (DU21445) and propranolol in patients with ischaemic heart disease.
Yan V; Sloman G
Aust N Z J Med; 1973 Oct; 3(5):467-73. PubMed ID: 4149632
[No Abstract] [Full Text] [Related]
9. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
12. [Haemodynamic characterization of a new beta-receptor blocker celiprolol (st1396) at rest and during ergometer exercise compared with propranolol (inderal) (author's transl)].
Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
Wien Klin Wochenschr; 1978 May; 90(10):350-4. PubMed ID: 26139
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
Gilfrich HJ; Rahn KH; Nicolescu RF
Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
[No Abstract] [Full Text] [Related]
14. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
Klempt HW; Bender F
Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
[No Abstract] [Full Text] [Related]
15. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
[No Abstract] [Full Text] [Related]
16. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
[TBL] [Abstract][Full Text] [Related]
17. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Prahl P; Prahl M
Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
[No Abstract] [Full Text] [Related]
18. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
Wagner G
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
[TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
Wolf P; Feller K; Femmer K
Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
[No Abstract] [Full Text] [Related]
20. Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure.
Piccirillo G; Luparini RL; Celli V; Moisè A; Lionetti M; Marigliano V; Cacciafesta M
Am J Cardiol; 2000 Dec; 86(12):1392-5, A6. PubMed ID: 11113424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
